ZACKS INVESTMENT MANAGEMENT

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1086483 Chicago, IL

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,553,715

+$559,752 QoQ

Shares Held

32,627

+5.8% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#216

of 664 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ZACKS INVESTMENT MANAGEMENT holds $33,185,332 across 8 Biotechnology names. HALO ranks #2 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	55,052	$27,345,979
2	HALO	Halozyme Therapeutics, Inc. This page	32,627	$2,553,715
3	ALNY	Alnylam Pharmaceuticals, Inc.	8,417	$2,533,769
4	AUPH	Aurinia Pharmaceuticals Inc.	36,687	$622,578
5	LCTX	Lineage Cell Therapeutics, Inc.	42,084	$55,130
6	AGEN	Agenus Inc	10,550	$32,283
7	INO	Inovio Pharmaceuticals, Inc.	26,435	$29,078
8	GERN	Geron Corp	10,000	$12,800

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,553,715	32,627	+5.8%	Shares	Sole	2026-08-13
2026-03-31	$1,993,963	30,852	+16.7%	Shares	Sole	2026-05-14
2025-12-31	$1,778,806	26,431	+1.2%	Shares	Sole	2026-02-17
2025-09-30	$1,915,713	26,121	-29.5%	Shares	Sole	2025-11-14
2021-12-31	$1,488,855	37,027	+6.4%	Shares	Sole	2022-02-15
2021-09-30	$1,415,867	34,805	+10.5%	Shares	Sole	2021-11-15
2021-06-30	$1,430,551	31,503	+0.5%	Shares	Sole	2021-08-16
2021-03-31	$1,306,939	31,349	+1.7%	Shares	Sole	2021-05-17
2020-12-31	$1,316,364	30,821	+15.4%	Shares	Sole	2021-02-16
2020-09-30	$701,859	26,707	-1.0%	Shares	Sole	2020-11-16
2020-06-30	$723,172	26,974	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.